Protagonist Therapeutics, INC (PTGX) — DEF 14A Filings

All DEF 14A filings from Protagonist Therapeutics, INC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Protagonist Therapeutics Files 2025 Proxy Statement — Apr 29, 2025 Risk: low
Protagonist Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 20, 2025. The filing outlines th
Protagonist Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 20, 2024 — Apr 26, 2024 Risk: low
Protagonist Therapeutics, Inc (PTGX) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Protagonist Therapeutics, Inc. will hold its 2024 Annual

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX